Fisher S - Search Results

1

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

Kaminski MS, Zasadny KR, Francis IR, Fenner MC, Ross CW, Milik AW, Estes J, Tuck M, Regan D, Fisher S, Glenn SD, Wahl RL. Kaminski MS, et al. Among authors: fisher s. J Clin Oncol. 1996 Jul;14(7):1974-81. doi: 10.1200/JCO.1996.14.7.1974. J Clin Oncol. 1996. PMID: 8683227 Clinical Trial.

2

131I-tositumomab therapy as initial treatment for follicular lymphoma.

Kaminski MS, Tuck M, Estes J, Kolstad A, Ross CW, Zasadny K, Regan D, Kison P, Fisher S, Kroll S, Wahl RL. Kaminski MS, et al. Among authors: fisher s. N Engl J Med. 2005 Feb 3;352(5):441-9. doi: 10.1056/NEJMoa041511. N Engl J Med. 2005. PMID: 15689582 Free article. Clinical Trial.

3

Intraperitoneal delivery of monoclonal antibodies: enhanced regional delivery advantage using intravenous unlabeled anti-mouse antibody.

Wahl RL, Fisher S. Wahl RL, et al. Among authors: fisher s. Int J Rad Appl Instrum B. 1987;14(6):611-5. doi: 10.1016/0883-2897(87)90034-1. Int J Rad Appl Instrum B. 1987. PMID: 3429242 Free article.

4

Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience.

Wahl RL, Zasadny KR, MacFarlane D, Francis IR, Ross CW, Estes J, Fisher S, Regan D, Kroll S, Kaminski MS. Wahl RL, et al. Among authors: fisher s. J Nucl Med. 1998 Aug;39(8 Suppl):21S-27S. J Nucl Med. 1998. PMID: 9708567 Clinical Trial.

5

Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience.

Kaminski MS, Estes J, Zasadny KR, Francis IR, Ross CW, Tuck M, Regan D, Fisher S, Gutierrez J, Kroll S, Stagg R, Tidmarsh G, Wahl RL. Kaminski MS, et al. Among authors: fisher s. Blood. 2000 Aug 15;96(4):1259-66. Blood. 2000. PMID: 10942366 Free article. Clinical Trial.

6

Intratumoral microdistribution of [131I]MB-1 in patients with B-cell lymphoma following radioimmunotherapy.

Brown RS, Kaminski MS, Fisher SJ, Chang AE, Wahl RL. Brown RS, et al. Among authors: fisher sj. Nucl Med Biol. 1997 Oct;24(7):657-63. doi: 10.1016/s0969-8051(97)00099-1. Nucl Med Biol. 1997. PMID: 9352537

7

Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Sugawara Y, Fisher SJ, Zasadny KR, Kison PV, Baker LH, Wahl RL. Sugawara Y, et al. Among authors: fisher sj. J Clin Oncol. 1998 Jan;16(1):173-80. doi: 10.1200/JCO.1998.16.1.173. J Clin Oncol. 1998. PMID: 9440740

8

Improved radioimmunolocalization of human tumor xenografts following subcutaneous delivery of monoclonal antibodies.

Wahl RL, Laino L, Fisher S, Schteingart M, Beierwaltes WH. Wahl RL, et al. Among authors: fisher s. Eur J Nucl Med. 1988;13(10):530-6. doi: 10.1007/BF00256630. Eur J Nucl Med. 1988. PMID: 3371375 Free article.

9

Investigations into the route of uptake and pharmacokinetics of intraperitoneally-administered monoclonal antibodies: I. Transdiaphragmatic blockade of the terminal lymphatics in the rat.

Barrett JS, Wahl RL, Wagner JG, Brown R, Fisher SJ. Barrett JS, et al. Among authors: fisher sj. Cancer Immunol Immunother. 1990;31(6):365-72. doi: 10.1007/BF01741408. Cancer Immunol Immunother. 1990. PMID: 2386982 Free PMC article.

10

Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma.

Brown RS, Fisher SJ, Wahl RL. Brown RS, et al. Among authors: fisher sj. J Nucl Med. 1993 Jan;34(1):75-82. J Nucl Med. 1993. PMID: 8418275 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,257 results

Search Page

Filters